SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study

Candace Makeda Moore; Ruslan Sergienko; Ronen Arbel

doi:10.1101/2021.08.17.21262167

Data Availability

The data for this article was made from the original publically available data of the Israel Ministry of Health online, and is cited. In some cases, data has been processed from this original data.

View the discussion thread.

Posted August 18, 2021.

Download PDF

Data/Code

Citation Tools

Subject Area

Epidemiology

Subject Areas

All Articles

Addiction Medicine (227)
Allergy and Immunology (500)
Anesthesia (110)
Cardiovascular Medicine (1226)
Dentistry and Oral Medicine (205)
Dermatology (147)
Emergency Medicine (282)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (528)
Epidemiology (9998)
Forensic Medicine (5)
Gastroenterology (497)
Genetic and Genomic Medicine (2441)
Geriatric Medicine (236)
Health Economics (479)
Health Informatics (1634)
Health Policy (750)
Health Systems and Quality Improvement (633)
Hematology (247)
HIV/AIDS (530)
Infectious Diseases (except HIV/AIDS) (11854)
Intensive Care and Critical Care Medicine (625)
Medical Education (251)
Medical Ethics (74)
Nephrology (267)
Neurology (2271)
Nursing (139)
Nutrition (349)
Obstetrics and Gynecology (451)
Occupational and Environmental Health (532)
Oncology (1244)
Ophthalmology (375)
Orthopedics (133)
Otolaryngology (226)
Pain Medicine (154)
Palliative Medicine (50)
Pathology (324)
Pediatrics (728)
Pharmacology and Therapeutics (311)
Primary Care Research (281)
Psychiatry and Clinical Psychology (2279)
Public and Global Health (4822)
Radiology and Imaging (833)
Rehabilitation Medicine and Physical Therapy (488)
Respiratory Medicine (650)
Rheumatology (283)
Sexual and Reproductive Health (237)
Sports Medicine (224)
Surgery (266)
Toxicology (44)
Transplantation (124)
Urology (99)

SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study

Data Availability

Citation Manager Formats

Subject Area